Overtreatment

Fashionable to criticise the drug industry?

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7089 (Published 24 October 2012)
Cite this as: BMJ 2012;345:e7089

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Stephen Whitehead, chief executive
  1. 1Association of the British Pharmaceutical Industry, London SW1E 6QT, UK
  1. press{at}abpi.org.uk

McCartney makes several disparate claims about the drug industry.1 She states that the financial relations between charities and the industry are “unclear” and implies that this unduly influences the daily activities of the third sector. In reality, the Association of the British Pharmaceutical Industry’s code of practice requires that companies publicly declare their financial transactions with charities and the nature of …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL